Interleukin-12 as a target for modulation of the inflammatory response in asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 2, 1998, Pages 113-119

  Wills Karp, M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN E; INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12; STEROID;

ALLERGIC ASTHMA; ANIMAL MODEL; ANTIGEN SPECIFICITY; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOPENIA; EOSINOPHILIA; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SPLENOMEGALY;

EID: 0031852598     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03858.x     Document Type: Review

References (59)

1. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
2. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthmatics. Am Rev Respir Dis 1990; 142:1407-13.
3. Corrigan CJ. Kay AB. CD4+ T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am Rev Respir Dis 1990;141:970-7.
4. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
5. Street NE, Mosmann TR. Functional diversity of T-lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5:171-7.
6. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
7. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
8. Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 1991;147:1387-91.
9. Finkelman FD, Katona IM, Urban JF, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988;141:2335-41.
10. Campbell HD, Tucker WQ, Hort Y, et al. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci U S A 1987;84:6629-33.
11. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19: 701-5.
12. Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
13. Gavett SH, Chen X, Finkelman FD, Wills-Karp M. Depletion of murine CD4+ T-lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Cell Mol Biol 1994;10:587-93.
14. Lukacs NW, Stricter RM, Chensue SW, Kunkel SL. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 1994; 10:526-32.
15. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol 1995;12:254-9.
16. Coyle AJ, LeGros G, Bertrand C, et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54-9.
17. van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, van Ark I, Delsman KJ, Nijkamp FP. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-52.
18. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
19. Gavett SH, O'Hearn DJ, Karp CL, et al. Interleukin-4 receptor blockade prevents airway responses induced byantigen challenge in mice. Am J Physiol 1997;272:L253-61.
20. Swain SL, Weinberg AD, Inglish M, Hutson G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990;145:3796-3806.
21. Seder RA, Paul WE, Davis MM, de Groth BF. The presence of interleukin 4 in in vitro priming determines the lymphokine-producing potential of CD4+ T cells through IL-12 produced by Listeria-induccd macrophages. J Exp Med 1992;176:1091-8.
22. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αß T-cell receptor transgenic system. Proc Natl Acad Sci U S A 1992;89:6065.
23. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
24. Locksley RM. Th2 cells: help for helminths. J Exp Med 1994;179:1405-7.
25. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-27.
26. Vezzio N, Sarfati M, Yang L, Demeure CE, Delespesse G. Human Th2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles. Int Immunol 1996;8:1963-70.
27. Marsh, DG, Neely JD, Breazeale DR, et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6.
28. Ma X, Chow JM, Gri G, et al. The interleukin-12 gene promoter is primed by interferon-γ in monocytic cells. J Exp Med 1996;183:147-57.
29. Meyaard L, Hovenkamp E, Otto SA, Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 156:2776-82.
30. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor-α production. J Exp Med 1995;181:537-46.
31. 2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995;181:775-9.
32. van der Pouw Kraan TCTM, Boeije LCM, de Groot ER, et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J Immunol 1997;158:5560-5.
33. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
34. Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-7.
35. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 1993;177;1505-9.
36. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992;90:262-6.
37. Morris SC, Madden KB, Adamovicz JJ, et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994;152:1047-56.
38. Finkelman FD, Madden KB, Cheever AW, et al. Effects of interleukin-12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994;179:1563-72.
39. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994;179: 1551-61.
40. Sypek JP, Chung CL, Mayor SEH, et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177: 1797-1802.
41. Murphy BE, Shibuya K, Hosken N, et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996;183:901-13.
42. Bliss J, Vancleave V, Murray K, et al. Interleukin 12 as an adjuvant promotes a T helper 1 but does not suppress a T helper 2 recall response. J Immunol 1996;156:887-94.
43. Gavett SH, O'Hearn DJ, Li X, Huang S, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
44. Kips JC, Brusselle GJ, Joos GF, et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996;153:535-9.
45. Lack G, Bradley KL, Hamelmann E, et al. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-9.
46. Li X, Chopra RK, Chou T, Schofield BH, Wills-Karp M, Huang S. Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996;157:3216-19.
47. Brusselle GG, Kips JC, Peleman RA, et al. Role of IFN-γ in the inhibition of the allergic airway inflammation caused by IL-12. Am J Respir Cell Mol 1997;17:767-71.
48. Korsgren M, Erjefält JS, Korsgren O, Sundler F, Persson CGA. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1996;185:885-92.
49. Mehlhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 1997;94:1344-9.
50. Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996;157:4173-80.
51. Hendrzak JA, Brunda MJ. Biology of disease: interleukin 12, biologic activity, therapeutic utility, and role in disease. Lab Invest 1995;72:619-37.
52. Leonard JP, Sherman ML, Fisher GL, et al. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-γ production. Blood 1997;90:2541-8.
53. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominant immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-44.
54. Bliss J, Maylor R, Stokes K, Murray KS, Ketchem MA, Wolf SF. Interleukin-12 as vaccine adjuvant. Ann N Y Acad Sci 1996;795:26-35.
55. Chen TT, Tao MH, Levy R. Idiotype-cytokine fusion protein as cancer vaccines: relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J Immunol 1994;153:4775.
56. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994;344: 456-8.
57. Naseer T, Minshall EM, Leung DYM, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-51.
58. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997;158:5589-95.
59. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-60.